After a number of development challenges and setbacks, Hikma has now received US Food and Drug Administration approval for and launched its generic version of GlaxoSmithKline’s Advair Diskus (fluticasone/salmeterol) in the US.
The launch – which comes slightly earlier than expected following a recent FDA complete response letter – puts Hikma in...



